Navigation Links
Advanced Market Research for Medical Device Manufacturers
Date:3/3/2011

DENVER, March 3, 2011 /PRNewswire-USNewswire/ -- AORN Works, a subsidiary of the Association of periOperative Registered Nurses (AORN), announced that its market research and surgical insights division will lead the strategic priorities of its business.

(Logo: http://photos.prnewswire.com/prnh/20101001/DC75398LOGO)

On behalf of clients, market research/surgical insights measure the attitudes of perioperative professionals who are the end users of medical products and services. The new strategy results from its niche ability to provide exceptional market intelligence to medical device manufacturers and service providers that sell to operating rooms throughout the United States.  

In addition to its market research division, AORN Works specializes in executive level interim and permanent placement services for perioperative departments.

"As a subsidiary of AORN, we have contact with more than 40,000 operating room professionals who we can use as a resource for our market research," said Vicki Faas, general manager for AORN Works.  "Through our opt- in market research database, we are also able to tap into a broad network of perioperative team members including OR nurses, management, scrub and central sterile technicians, surgeons and anesthesiologists."

AORN Works conducts research that translates into actionable information to expedite the development of products and services that benefit surgical patients in the ambulatory surgery and hospital settings.  Capabilities include market needs assessments, target market analysis, voice of the customer, product testing, strategic advisory boards, marketing communications development and testing, customer satisfaction and forecasting.

About AORN Works

Headquartered
'/>"/>

SOURCE AORN Works
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015  Boston Scientific Corporation (NYSE: ... 2015 Annual Healthcare Conference on March 10 in ... Brennan , executive vice president and chief financial officer, ... will participate in a 25-minute question and answer session ... 1:05 p.m. ET. Following a 5-minute break, a question ...
(Date:2/27/2015)... SOUTH PLAINFIELD, N.J., Feb. 27, 2015  PTC Therapeutics, ... corporate update and reported financial results for the fourth ... "2014 was a transformative year for PTC. ... on delivering and developing RNA-targeted therapies in the rare ... Officer, PTC Therapeutics, Inc. "We are proud to bring ...
(Date:2/27/2015)... and JERUSALEM , Feb. 27, 2015 ... octreotide capsules, its lead product for the orphan condition ... Series E financing round. Participants in the financing included ... an undisclosed blue chip public investment fund, as well ... Health Ventures, Abingworth and ARCH Venture Partners. ...
Breaking Medicine Technology:Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3
... highlight significant advances in treatment and survival outcomes for ... bleeding disorders characterized by a low number of platelets ... conference on Saturday, December 6, at 8:00 a.m., during ... Hematology in San Francisco, CA. The studies featured in ...
... Dec. 5 Bayer HealthCare Pharmaceuticals Inc. announced today ... be presented at the 50th Annual Meeting of the ... in San Francisco, California. , , ... research centers will present data through several oral and ...
Cached Medicine Technology:Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders 2Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders 3Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders 4Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders 5Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders 6Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders 7Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders 8Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders 9Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 2Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 3Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 4Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 5Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 6
(Date:2/27/2015)... Cary, NC (PRWEB) February 27, 2015 ... nation’s leading cancer research funding organizations, is excited to ... varied ways to participate and many long-standing partnerships highlight ... cancer and focus on expanding ways for all to ... cash donations to cutting-edge cancer research, The V Foundation ...
(Date:2/27/2015)... According to court documents, Donna Pirolli was a ... and underwent a procedure during which a duodenoscope was ... the duodenoscope allegedly had not been properly cleaned, Donna ... (CRE). , A lawsuit has been proceeding ... of Ms. Pirolli alleging that Lutheran General Hospital was ...
(Date:2/27/2015)... Winter is here, and with it comes harsh ... snow and ice can be harmful on a dog’s paws. ... Puppy Store is ready to help pet owners know what ... the winter time. , Ice melts can lead to several ... Ingestion of ice melt products may cause depression, loss of ...
(Date:2/27/2015)... 2015 FACE Skincare~Medical~Wellness, a multiaward-winning ... a unique combination to take fifteen years off ... is a new treatment introduced that is the ... indicated to improve lines and wrinkles on the ... who suffers from the stubborn vertical lines between ...
(Date:2/27/2015)... Glidewell Laboratories, industry-leading provider of ... its CloudPoint™ family of equipment, software ... monolithic zirconia crowns & bridges, CloudPoint offers dental ... CAD/CAM-produced restorations that doctors demand. Installation of CloudPoint ... can be scanned, managed and produced. After scanning ...
Breaking Medicine News(10 mins):Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 2Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 3Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:The Puppy Store Helps Dogs Prepare for Harsh Winter Conditions 2Health News:Face Skincare Announces New Combination Therapy 2Health News:Glidewell Laboratories Announces Release of CloudPoint™ FastScan™ and FastDesign™ 2Health News:Glidewell Laboratories Announces Release of CloudPoint™ FastScan™ and FastDesign™ 3
... International Auto Show to raise money for breast cancer education and ... research., - The ... the Cure - to $500 for each Warriors in Pink Mustang sold., ... cash and in-kind contributions for breast cancer education and research., NEW YORK, March 19 ...
... Vista Partners announced today,that it has initiated coverage on ... "Cash on hand and royalty,revenue alone are equal to ... probability weighted, DCF value for ART621 and you have ... This comes without assigning any,value to their current pre-clinical ...
... Inc. (OTC,Bulletin Board: RXEI), a developer, manufacturer, and marketer ... discuss its,2007 year-end financial results in a conference call ... The Company will release its 2007 year-end financial results ... the call will be,RxElite CEO Jonathan Houssian, COO Earl ...
... U.S. Secretary of Health and Human Services ... to Ensure Safety/Quality, WASHINGTON, March 18 ... Michael O. Leavitt,Secretary, U.S. Department of Health and ... observations from his recent visit to,India, recommending collaboration ...
... SAN FRANCISCO, March 18 W. Scott Harkonen,M.D., ... on wire fraud and,felony Food, Drug and Cosmetic ... and,dissemination of false and misleading information about the ... treatment for,idiopathic pulmonary fibrosis (IPF), the Justice Department ...
... Encourages use of electronic health records to improve ... At a meeting,today, HHS Deputy Secretary Tevi ... community leaders as a Chartered,Value Exchange (CVE) for ... health care. With this special federal distinction, the ...
Cached Medicine News:Health News:Ford Launches 'Warriors in Pink' Mustang for '09, Doubles Contributions To Race For The Cure 2Health News:Vista Partners Initiates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx) 2Health News:RxElite Inc. Fourth Quarter and Year-End 2007 Earnings Release and Conference Call Notice 2Health News:U.S.-India Business Council Mobilizes Coalition for Healthy India 2Health News:Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations 2Health News:Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations 3Health News:Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations 4Health News:HHS Deputy Secretary Recognizes Grand Rapids Leaders for Improving Quality and Value in Health Care 2Health News:HHS Deputy Secretary Recognizes Grand Rapids Leaders for Improving Quality and Value in Health Care 3Health News:HHS Deputy Secretary Recognizes Grand Rapids Leaders for Improving Quality and Value in Health Care 4
Bravo Vacuum Pump. Complete with tubing....
Bravo Calibration Tubes...
Buffer solution is needed to calibrate pH catheters. The specific chloride ion concentration in the Medtronic buffers is required for proper function of your Medtronic pH measurement system. Buffer s...
... Slimline multi-use catheters are designed ... solution with the following benefits:, ... reference: ,In procedures where the multi-use ... Gel creates stable contact to the ...
Medicine Products: